COMMUNIQUÉS West-GlobeNewswire

Kiadis Pharma to present at HollandBIO's Dutch Biotech Event 2018

25/06/2018 - 07:01

Kiadis Pharma to present at HollandBIO's Dutch Biotech Event 2018 Amsterdam, The Netherlands, June 25, 2018 - Kiadis Pharma N.V. ("Kiadis Pharma" or the "Company") (Euronext Amsterdam and Brussels: KDS ), a clinical [...]

MiniMed 670G System Real-World Data Show Improved Time in Range and Reduced Lows and Highs Across All Patient Groups Including a 41 Percent Time in Range Improvement for Previous MDI Patients

25/06/2018 - 01:49

DUBLIN - June 24, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for 32,178 users of the MiniMed(TM) 670G system. Data on more than 2 million [...]

ERYTECH Confirms Strategic Focus of Eryaspase on Solid Tumors and Ceases Development in Acute Lymphoblastic Leukemia

24/06/2018 - 22:51

Conference call on Monday, June 25th at 2:30 pm CET/8:30 am EDT Focuses development efforts on solid tumor indications Confirms planned launch of company-sponsored randomized Phase 2 trial in first-line pancreatic [...]

ERYTECH confirme l’orientation stratégique d’eryaspase dans les tumeurs solides et interrompt ses développements dans la Leucémie Aiguë Lymphoblastique (LAL)

24/06/2018 - 22:51

Conférence téléphonique lundi 25 juin à 14h30 (heure de Paris) Concentration du développement sur les indications de tumeurs solides Confirmation du lancement d’un essai randomisé de Phase 2 dans le traitement de [...]

Lexicon Pharmaceuticals Announces Positive 52-Week Results From Sotagliflozin inTandem1 Study Presented at ADA 2018 and Published in Diabetes Care

24/06/2018 - 22:01

Sotagliflozin, in Combination with Insulin, Decreased A1C Levels and Weight in Adults with Type 1 Diabetes THE WOODLANDS, Texas, June 24, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq:LXRX), today [...]

Phillips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards

24/06/2018 - 15:02

ARLINGTON, Va., June 24, 2018 (GLOBE NEWSWIRE) -- Today IMV, part of the Science and Medicine Group, and the leading market research and business intelligence provider to the Imaging industry, announced the category [...]

Lexicon Pharmaceuticals Announces Positive 52-Week Results From Sotagliflozin inTandem2 Study Presented at ADA 2018 and Published in Diabetes Care

23/06/2018 - 19:30

Sotagliflozin, in Combination with Insulin, Significantly Decreased A1C Levels and Reduced Weight at 52 Weeks Results Observed at 24 Weeks Persisted at 52 Weeks THE WOODLANDS, Texas, June 23, 2018 (GLOBE NEWSWIRE) -- [...]

Oral semaglutide demonstrated significant reduction in blood sugar vs placebo in PIONEER 1 trial

23/06/2018 - 16:03

Orlando, US, 23 June 2018 - Oral semaglutide, an investigational GLP-1 analogue taken as a once-daily tablet, achieved significant reductions in blood sugar versus placebo in adults with type 2 diabetes, according to [...]

Ozempic® provided greater weight reductions for adults with a baseline BMI of or above 25 kg/m2 than those with lower baseline BMI <25 kg/m2, in a SUSTAIN 7 post-hoc analysis

23/06/2018 - 16:02

Orlando, US, 23 June 2018 - Ozempic ® (semaglutide) 0.5 mg or 1.0 mg provided greater weight reductions vs dulaglutide 0.75 mg or 1.5 mg, respectively, in adults with type 2 diabetes, regardless of baseline body mass [...]

Zealand Pharma presents two dasiglucagon milestone studies at the 78th Scientific Sessions of the American Diabetes Association (ADA)

23/06/2018 - 16:02

Press Release - No. 17/2018 Zealand Pharma presents two dasiglucagon milestone studies at the 78th Scientific Sessions of the American Diabetes Association (ADA) Low doses of dasiglucagon effectively counteract low [...]

Tresiba® demonstrated significantly improved blood sugar control and lower rates of hypoglycaemia versus insulin glargine U300 in real-world evidence study

23/06/2018 - 16:01

Adults with type 2 diabetes treated with Tresiba ® (insulin degludec injection) had a significant reduction in HbA 1c and a 30% lower rate of hypoglycaemic episodes after starting basal insulin Orlando, US, 23 June 2018 [...]

Survey demonstrating underuse of glucagon rescue kits in type 1 diabetes patients to be presented at the ADA's 78th Scientific Sessions

23/06/2018 - 16:00

Press Release - No. 16/2018 Survey demonstrating underuse of glucagon rescue kits in type 1 diabetes patients to be presented at the ADA's 78th Scientific Sessions T1D Exchange and Dr. Morey Haymond, MD, to present a [...]

MannKind Presents Positive Afrezza® Clinical Data from STAT and AFFINITY Studies at ADA 78th Scientific Sessions

23/06/2018 - 16:00

Poster 1017-P: Afrezza provides improved Time-in-Range on Continuous Glucose Monitoring compared to insulin aspart Poster 102-LB: Hypoglycemia is reduced with use of Afrezza compared to insulin aspart WESTLAKE VILLAGE, [...]

Zafgen Announces Positive Full Results in Phase 2 Proof-of-Concept Trial of ZGN-1061 in Patients with Difficult-to-Control Type 2 Diabetes

23/06/2018 - 16:00

Trial met all primary objectives, demonstrated efficacy and safety and established minimally effective dose of 0.9 mg for ZGN-1061 Patient dosing recently initiated for the 1.8 mg dose cohort Zafgen presenting the Phase [...]

Significant blood sugar improvement with Xultophy® compared to insulin glargine U-100 when used as add-on to oral diabetes medications

23/06/2018 - 14:01

Adults with type 2 diabetes treated with Xultophy ® (insulin degludec and liraglutide injection) also experienced no change in body weight, lower rates of hypoglycaemia and a lower insulin dose at 26 weeks Bagsværd, [...]

BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Due to Popular Demand

23/06/2018 - 14:00

Company surpasses $1M in accepted investments; expects to make significant scientific announcement in the near future CHICAGO, June 23, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D , a biotech pioneer leveraging advances in [...]

Artificial Intelligence-Powered Sugar.IQ(TM) Diabetes Management App Developed by Medtronic and IBM Watson Health Now Commercially Available

23/06/2018 - 00:16

Real-World Experience Data on Sugar.IQ App Use Presented at the 78th Scientific Sessions of the American Diabetes Association DUBLIN AND CAMBRIDGE - June 22, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical [...]

Healthcare Special Opportunities Fund Announces June 2018 Quarterly Distribution

22/06/2018 - 23:00

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, June 22, 2018 (GLOBE NEWSWIRE) -- (TSX:MDS.UN) – LDIC Inc. (the “ Manager ”), the manager of Healthcare Special [...]

Analogic Announces Completion of Acquisition by an Affiliate of Altaris Capital Partners

22/06/2018 - 22:30

Investment by Altaris Supports Analogic’s Capabilities to Deliver Innovative Solutions and Service to its Customers PEABODY, Mass. and NEW YORK, June 22, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation (NASDAQ:ALOG) (“the [...]